Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

305

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Psoriasis
Interventions
DRUG

clobetasol propionate spray 0.05%

clobetasol propionate spray, 0.05%, applied topically twice daily

DRUG

calcitriol ointment

calcitriol ointment, 3 µg/g, applied topically, not to exceed 30 g daily

Trial Locations (12)

10029

Mount Sinai Department of Dermatology, New York

23507

Virginia Clinical Research, Inc, Norfolk

30078

Gwinnett Clinical Research Center, Inc, Snellville

30263

MedaPhase, Inc., Newnan

44483

Northeastern Ohio Universities College of Medicine, Warren

47714

Hudson Dermatology, Evansville

53719

Madison Skin and Research, Inc, Madison

73069

Central Sooner Research, Norman

75390

Suzanne Bruce and Associates, PA, Houston

77840

J&J Studies, Inc, College Station

92123

Therapeutics Clinical Research, San Diego

98101

Dermatology Associates of Seattle, PLLC, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY